Literature DB >> 1659597

Hepatitis A virus attachment to cultured cell lines.

J T Stapleton1, J Frederick, B Meyer.   

Abstract

Identification of a hepatitis A virus (HAV) receptor is important for understanding HAV tissue tropism and replication sites and in the design of vaccines and antiviral therapy. The attachment of HAV to cultured cell lines was evaluated: Calcium-dependent specific attachment of four HAV strains to permissive cells occurred, whereas binding to nonpermissive cells did not. Investigation of HAV antigenic variant strains (neutralization escape mutants) demonstrated identical attachment properties with neutralization-susceptible strains, suggesting that the immunodominant neutralization antigenic site of HAV is not directly involved in cell attachment. Unlike foot-and-mouth-disease virus, a related picornavirus, RGD peptides (arginine-glycine-aspartic acid) were unable to interfere with HAV attachment. These studies demonstrate that HAV has a calcium-dependent receptor on cultured cell lines and suggest that the HAV binding region does not involve an RGD sequence or the HAV immunodominant neutralization site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659597     DOI: 10.1093/infdis/164.6.1098

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Uncoating kinetics of hepatitis A virus virions and provirions.

Authors:  N E Bishop; D A Anderson
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.

Authors:  J T Stapleton; V Raina; P L Winokur; K Walters; D Klinzman; E Rosen; J H McLinden
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

4.  Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Authors:  G Kaplan; A Totsuka; P Thompson; T Akatsuka; Y Moritsugu; S M Feinstone
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

5.  Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.

Authors:  J Xiang; D Klinzman; J McLinden; W N Schmidt; D R LaBrecque; R Gish; J T Stapleton
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM.

Authors:  Hyeok-Jin Lee; Hye Sook Jeong; Byung-Ki Cho; Mi-Jeong Ji; Ji-Ha Kim; An-Na Lee; Kyoung-Ryul Lee; Doo-Sung Cheon
Journal:  Virol J       Date:  2010-07-19       Impact factor: 4.099

7.  Capsid functions of inactivated human picornaviruses and feline calicivirus.

Authors:  Suphachai Nuanualsuwan; Dean O Cliver
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

8.  Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.

Authors:  F D LaBrecque; D R LaBrecque; D Klinzman; S Perlman; J B Cederna; P L Winokur; J Q Han; J T Stapleton
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture.

Authors:  Erica Silberstein; Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

10.  Development of lectin-linked immunomagnetic separation for the detection of hepatitis a virus.

Authors:  Sang-Mu Ko; Joseph Kwon; Bipin Vaidya; Jong Soon Choi; Hee-Min Lee; Myung-Joo Oh; Hyeun-Jong Bae; Se-Young Cho; Kyung-Seo Oh; Duwoon Kim
Journal:  Viruses       Date:  2014-03-04       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.